These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25754447)

  • 1. Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonism.
    Khan MM; Zaheer S; Thangavel R; Patel M; Kempuraj D; Zaheer A
    Neurochem Res; 2015 May; 40(5):980-90. PubMed ID: 25754447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice.
    Selvakumar GP; Ahmed ME; Thangavel R; Kempuraj D; Dubova I; Raikwar SP; Zaheer S; Iyer SS; Zaheer A
    Brain Behav Immun; 2020 Jul; 87():429-443. PubMed ID: 31982500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation.
    Kempuraj D; Selvakumar GP; Thangavel R; Ahmed ME; Zaheer S; Kumar KK; Yelam A; Kaur H; Dubova I; Raikwar SP; Iyer SS; Zaheer A
    J Alzheimers Dis; 2018; 66(3):1117-1129. PubMed ID: 30372685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of glia maturation factor expression prevents 1-methyl-4-phenylpyridinium (MPP⁺)-induced loss of mesencephalic dopaminergic neurons.
    Khan MM; Zaheer S; Nehman J; Zaheer A
    Neuroscience; 2014 Sep; 277():196-205. PubMed ID: 25016212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
    Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM
    Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RESP18 deficiency has protective effects in dopaminergic neurons in an MPTP mouse model of Parkinson's disease.
    Su J; Wang H; Yang Y; Wang J; Li H; Huang D; Huang L; Bai X; Yu M; Fei J; Huang F
    Neurochem Int; 2018 Sep; 118():195-204. PubMed ID: 29964075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
    Choi DY; Lee MK; Hong JT
    Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glia Maturation Factor (GMF) Regulates Microglial Expression Phenotypes and the Associated Neurological Deficits in a Mouse Model of Traumatic Brain Injury.
    Ahmed ME; Selvakumar GP; Kempuraj D; Raikwar SP; Thangavel R; Bazley K; Wu K; Khan O; Khan A; Zaheer S; Iyer S; Burton C; James D; Zaheer A
    Mol Neurobiol; 2020 Nov; 57(11):4438-4450. PubMed ID: 32737763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons.
    Hong J; Sha S; Zhou L; Wang C; Yin J; Chen L
    Cell Death Dis; 2015 Jul; 6(7):e1832. PubMed ID: 26203861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Association of Glia Maturation Factor with the Autophagic Machinery in Rat Dopaminergic Neurons: a Role for Endoplasmic Reticulum Stress and MAPK Activation.
    Selvakumar GP; Iyer SS; Kempuraj D; Ahmed ME; Thangavel R; Dubova I; Raikwar SP; Zaheer S; Zaheer A
    Mol Neurobiol; 2019 Jun; 56(6):3865-3881. PubMed ID: 30218400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
    Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
    Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
    González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
    J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice lacking Faim2 show increased cell death in the MPTP mouse model of Parkinson disease.
    Komnig D; Schulz JB; Reich A; Falkenburger BH
    J Neurochem; 2016 Dec; 139(5):848-857. PubMed ID: 27638043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mediators resulting from transglutaminase 2 expressed in mast cells contribute to the development of Parkinson's disease in a mouse model.
    Hong GU; Cho JW; Kim SY; Shin JH; Ro JY
    Toxicol Appl Pharmacol; 2018 Nov; 358():10-22. PubMed ID: 30195017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nurr1 Ligand,1,1-bis(3'-Indolyl)-1-(
    Hammond SL; Popichak KA; Li X; Hunt LG; Richman EH; Damale PU; Chong EKP; Backos DS; Safe S; Tjalkens RB
    J Pharmacol Exp Ther; 2018 Jun; 365(3):636-651. PubMed ID: 29626009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators.
    Kempuraj D; Thangavel R; Yang E; Pattani S; Zaheer S; Santillan DA; Santillan MK; Zaheer A
    PLoS One; 2015; 10(8):e0135776. PubMed ID: 26275153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage.
    Zaheer A; Zaheer S; Thangavel R; Wu Y; Sahu SK; Yang B
    Brain Res; 2008 May; 1208():192-203. PubMed ID: 18395194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.
    Annese V; Herrero MT; Di Pentima M; Gomez A; Lombardi L; Ros CM; De Pablos V; Fernandez-Villalba E; De Stefano ME
    Brain Struct Funct; 2015 Mar; 220(2):703-27. PubMed ID: 24558048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.
    Al-Sweidi S; Morissette M; Bourque M; Di Paolo T
    Neuropharmacology; 2011 Sep; 61(4):583-91. PubMed ID: 21586296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.